Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 13.37% vs 17.94% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 120.60% vs 2,561.14% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 40.16% vs 46.60% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -46.65% vs 122.48% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Astellas Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.66% vs 10.12% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 13.37% vs 17.94% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 15.77% vs -8.64% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 120.60% vs 2,561.14% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -1.51% vs 42.99% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 40.16% vs 46.60% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -54.34% vs 50.96% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -46.65% vs 122.48% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






